Michael J Coleman
CIK 1039011 · Voir sur SEC EDGAR ↗
Dirigeant
Première déclaration SEC: 1 octobre 2010 · Dernier: 1 octobre 2010
Sur cette page
Dirigeant chez
Transactions d'initiés
0 achats (P)
0 ventes (S)
Net:
$0
+ 93 transactions non-marché ci-dessous
12 derniers mois, basé sur les transactions ci-dessous
Variation du prix par rapport à la cotation actuelle, ajustée des divisions pour les actions d'entreprise depuis le dépôt — non comparée à un indice de référence, non annualisée, non pondérée par la taille
93 autres dépôts masqués
| Date | Ticker | Code | Actions | Prix | Valeur | Possédé après | Δ possédé | A/D | vs maintenant |
|---|---|---|---|---|---|---|---|---|---|
| 10 mai 2019 | XRAY | S | 9 160 | $54,90 | $502 884 | 22 223 Direct | -29,19% | Cédé | -80,1% (prix au 2026-08-20) |
| 1 juin 2018 | XRAY | S | 1 196 | $43,98 | $52 600 | 22 118 Direct | -5,13% | Cédé | -75,1% (prix au 2026-08-20) |
| 1 juin 2018 | XRAY | S | 4 842 | $43,97 | $212 903 | 22 118 Direct | -17,96% | Cédé | -75,1% (prix au 2026-08-20) |
| 10 mai 2018 | XRAY | S | 414 | $46,66 | $19 317 | 20 236 Direct | -2,00% | Cédé | -76,6% (prix au 2026-08-20) |
| 21 février 2017 | XRAY | S | 481 | $62,73 | $30 173 | 8 312 Direct | -5,47% | Cédé | -82,6% (prix au 2026-08-20) |
| 20 février 2015 | XRAY | S | 18 000 | $52,47 | $944 460 | 6 879 Direct | -72,35% | Cédé | -79,1% (prix au 2026-08-20) |
| 3 mai 2012 | XRAY | S | 18 000 | $40,19 | $723 420 | 6 877 Direct | -72,36% | Cédé | -72,8% (prix au 2026-08-20) |
Affichage des 100 dernières transactions sur 183
P = Achat sur le marché · S = Vente · A = Attribution/prix · M = Exercice d'option · G = Don · F = Retenue d'impôt
Les transactions d'initiés ne constituent pas une recommandation ; les ventes sont souvent motivées par des raisons de liquidité ou fiscales.
Participations dans des produits dérivés (Formulaire 4 Tableau II)
Options, RSUs et titres convertibles déclarés dans le Formulaire 4 Tableau II.
| Date | Ticker | Titre | Sous-jacent | Prix d'exercice | Expiration | Actions | A/D |
|---|---|---|---|---|---|---|---|
| 10 mai 2019 | XRAY | Stock Option (Right to Buy) | Common Stock (9 160) | $29,70 | 12 mai 2019 | 9 160 | Cédé |
| 12 avril 2019 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (33) | — | — | 33 | Acquis |
| 11 janvier 2019 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (42) | — | — | 42 | Acquis |
| 12 octobre 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (26) | — | — | 26 | Acquis |
| 13 juillet 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (37) | — | — | 37 | Acquis |
| 1 juin 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (1 196) | $39,39 | 28 juillet 2018 | 1 196 | Cédé |
| 1 juin 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (4 842) | $37,69 | 11 juin 2018 | 4 842 | Cédé |
| 23 mai 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (8 500) | $46,50 | 23 mai 2028 | 8 500 | Acquis |
| 10 mai 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (414) | $41,07 | 13 mai 2018 | 414 | Cédé |
| 13 avril 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (34) | — | — | 34 | Acquis |
| 12 janvier 2018 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Acquis |
| 29 décembre 2017 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (25) | — | — | 25 | Acquis |
| 13 octobre 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (15) | — | — | 15 | Acquis |
| 29 septembre 2017 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (28) | — | — | 28 | Acquis |
| 14 juillet 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Acquis |
| 30 juin 2017 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Acquis |
| 24 mai 2017 | XRAY | Stock Option (Right to Buy) | Common Stock (7 300) | $62,73 | 24 mai 2027 | 7 300 | Acquis |
| 14 avril 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (15) | — | — | 15 | Acquis |
| 31 mars 2017 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (27) | — | — | 27 | Acquis |
| 21 février 2017 | XRAY | Stock Option | Common Stock (481) | $36,49 | 31 juillet 2017 | 481 | Cédé |
| 13 janvier 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Acquis |
| 30 décembre 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Acquis |
| 14 octobre 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Acquis |
| 4 octobre 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Acquis |
| 8 juillet 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Acquis |
| 5 juillet 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (23) | — | — | 23 | Acquis |
| 25 mai 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 214) | — | 25 mai 2017 | 1 214 | Acquis |
| 25 mai 2016 | XRAY | Stock Option (Right to Buy) | Common Stock (5 800) | $61,77 | 25 mai 2026 | 5 800 | Acquis |
| 21 mai 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 433) | — | 21 mai 2016 | 1 433 | Cédé |
| 21 mai 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 431) | — | 21 mai 2016 | 1 431 | Cédé |
| 8 avril 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Acquis |
| 22 mars 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (23) | — | — | 23 | Acquis |
| 8 janvier 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Acquis |
| 15 décembre 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (23) | — | — | 23 | Acquis |
| 9 octobre 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (15) | — | — | 15 | Acquis |
| 22 septembre 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Acquis |
| 10 juillet 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (15) | — | — | 15 | Acquis |
| 23 juin 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Acquis |
| 21 mai 2015 | XRAY | Stock Option | Common Stock (6 700) | $52,61 | 21 mai 2025 | 6 700 | Acquis |
| 21 mai 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 426) | — | — | 1 426 | Acquis |
| 10 avril 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Acquis |
| 24 mars 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (24) | — | — | 24 | Acquis |
| 20 février 2015 | XRAY | Stock Option | Common Stock (18 000) | $28,00 | 11 juin 2015 | 18 000 | Cédé |
| 9 janvier 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Acquis |
| 23 décembre 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (23) | — | — | 23 | Acquis |
| 10 octobre 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Acquis |
| 23 septembre 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (27) | — | — | 27 | Acquis |
| 11 juillet 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Acquis |
| 24 juin 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Acquis |
| 21 mai 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 390) | — | — | 1 390 | Acquis |
| 21 mai 2014 | XRAY | Stock Option | Common Stock (6 500) | $46,77 | 21 mai 2024 | 6 500 | Acquis |
| 11 avril 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Acquis |
| 24 mars 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (27) | — | — | 27 | Acquis |
| 10 janvier 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (10) | — | — | 10 | Acquis |
| 26 décembre 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (24) | — | — | 24 | Acquis |
| 11 octobre 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Acquis |
| 24 septembre 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Acquis |
| 12 juillet 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (12) | — | — | 12 | Acquis |
| 25 juin 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (29) | — | — | 29 | Acquis |
| 22 mai 2013 | XRAY | Stock Option | Common Stock (6 200) | $41,47 | 22 mai 2023 | 6 200 | Acquis |
| 22 mai 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 567) | — | — | 1 567 | Acquis |
| 12 avril 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (9) | $0,00 | — | 9 | Acquis |
| 22 mars 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (24) | — | — | 24 | Acquis |
| 11 janvier 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (9) | — | — | 9 | Acquis |
| 20 décembre 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Acquis |
| 24 septembre 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (27) | — | — | 27 | Acquis |
| 13 juillet 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | $37,81 | — | 7 | Acquis |
| 25 juin 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (28) | — | — | 28 | Acquis |
| 23 mai 2012 | XRAY | Stock Option | Common Stock (6 900) | $38,02 | 23 mai 2022 | 6 900 | Acquis |
| 23 mai 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1 710) | $0,00 | — | 1 710 | Acquis |
| 3 mai 2012 | XRAY | Stock Option | Common Stock (18 000) | $18,63 | 11 juin 2012 | 18 000 | Cédé |
| 13 avril 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | $40,13 | — | 6 | Acquis |
| 23 mars 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Acquis |
| 10 janvier 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | $34,99 | — | 7 | Acquis |
| 6 octobre 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | $32,43 | — | 7 | Acquis |
| 8 juillet 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | $38,08 | — | 6 | Acquis |
| 8 juillet 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (54) | $38,08 | — | 54 | Acquis |
| 27 juin 2011 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Acquis |
| 25 mai 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (894) | $0,00 | — | 894 | Acquis |
| 25 mai 2011 | XRAY | Stock Option | Common Stock (7 600) | $38,57 | 25 mai 2021 | 7 600 | Acquis |
| 8 avril 2011 | XRAY | RSU (Restricted Stock Unit) Granted | Common Stock (5) | $36,49 | — | 5 | Acquis |
| 25 mars 2011 | XRAY | Directors' Deferred Comp (DDC) | Common Stock (25) | $36,14 | — | 25 | Acquis |
| 7 janvier 2011 | XRAY | RSU (Restricted Stock Unit) Granted [F1] | Common Stock (5) | $34,54 | — | 5 | Acquis |
| 27 décembre 2010 | XRAY | Directors' Deferred Comp (DDC) | Common Stock (26) | $34,54 | — | 26 | Acquis |
| 7 octobre 2010 | XRAY | RSU (Restricted Stock Unit) Granted [F1] | Common Stock (5) | $31,87 | — | 5 | Acquis |
| 29 septembre 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (29) | — | — | 29 | Acquis |
| 30 juillet 2010 | XRAY | RSU (Restricted Stock Unit) | Common Stock (876) | — | 31 juillet 2017 | 876 | Cédé |
| 8 juillet 2010 | XRAY | Additional RSUs [F1] | Common Stock (7) | $31,03 | — | 7 | Acquis |
| 28 juin 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (29) | — | — | 29 | Acquis |
| 6 avril 2010 | XRAY | Additional RSUs [F1] | Common Stock (5) | $34,17 | — | 5 | Acquis |
| 24 mars 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (26) | — | — | 27 | Acquis |
| 9 janvier 2010 | XRAY | Additional RSUs [F1] | Common Stock (4) | $35,44 | — | 4 | Acquis |
| 18 décembre 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (26) | — | — | 26 | Acquis |
| 6 octobre 2009 | XRAY | Phantom Stock (Deferred Compensation) | Common Stock (26) | $34,64 | — | 26 | Acquis |
| 6 octobre 2009 | XRAY | Additional RSUs [F1] | Common Stock (5) | $33,60 | — | 5 | Acquis |
| 7 juillet 2009 | XRAY | Additional RSUs [F1] | Common Stock (5) | $30,93 | — | 5 | Acquis |
| 22 juin 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (31) | $29,27 | — | 31 | Acquis |
| 12 mai 2009 | XRAY | Stock Option | Common Stock (3 053) | $29,70 | 12 mai 2019 | 3 053 | Acquis |
| 12 mai 2009 | XRAY | Stock Option | Common Stock (3 054) | $29,70 | 12 mai 2019 | 3 054 | Acquis |
| 12 mai 2009 | XRAY | Stock Option | Common Stock (3 053) | $29,70 | 12 mai 2019 | 3 053 | Acquis |
Affichage des 100 dernières transactions sur 152
Le prix d'exercice/conversion est vide lorsqu'il n'est pas applicable (par exemple, pour les RSUs).